Evidence map›Paper›PMID 27867586›Full record

ArticleJournal of thoracic disease2016

Autofluorescence imaging bronchoscopy as a novel approach to the management of tracheobronchopathia osteochondroplastica: a case report.

Hiroaki Ihara, Ken Tajima, Hitomi Yoshikawa, Manabu Tajima, Norihiro Harada, Fumiyuki Takahashi, Toshimasa Uekusa, Tetsutaro Nagaoka, Kazuhisa Takahashi

Abstract readCase Reports
In one paragraph

Article in Journal of thoracic disease, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Clinicopathological Features and Management Principles of Tracheobronchopathia Osteochondroplastica - A Scoping Review.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hiroaki IharaDepartment of Respiratory Medicine, Juntendo University, Faculty of Medicine, Tokyo, Japan;; Research Institute for Diseases of Old Ages, Juntendo University, Faculty of Medicine, Tokyo, Japan.
Ken TajimaDepartment of Respiratory Medicine, Juntendo University, Faculty of Medicine, Tokyo, Japan;; Research Institute for Diseases of Old Ages, Juntendo University, Faculty of Medicine, Tokyo, Japan.
Hitomi YoshikawaDepartment of Respiratory Medicine, Juntendo University, Faculty of Medicine, Tokyo, Japan;; Research Institute for Diseases of Old Ages, Juntendo University, Faculty of Medicine, Tokyo, Japan.
Manabu TajimaDepartment of Respiratory Medicine, Juntendo University, Faculty of Medicine, Tokyo, Japan;; Research Institute for Diseases of Old Ages, Juntendo University, Faculty of Medicine, Tokyo, Japan.
Norihiro HaradaDepartment of Respiratory Medicine, Juntendo University, Faculty of Medicine, Tokyo, Japan;; Research Institute for Diseases of Old Ages, Juntendo University, Faculty of Medicine, Tokyo, Japan.
Fumiyuki TakahashiDepartment of Respiratory Medicine, Juntendo University, Faculty of Medicine, Tokyo, Japan;; Research Institute for Diseases of Old Ages, Juntendo University, Faculty of Medicine, Tokyo, Japan.
Toshimasa UekusaDepartment of Pathology, Labor Health and Welfare Organization Kanto Rosai Hospital, Kawasaki, Japan.
Tetsutaro NagaokaDepartment of Respiratory Medicine, Juntendo University, Faculty of Medicine, Tokyo, Japan;; Research Institute for Diseases of Old Ages, Juntendo University, Faculty of Medicine, Tokyo, Japan.
Kazuhisa TakahashiDepartment of Respiratory Medicine, Juntendo University, Faculty of Medicine, Tokyo, Japan;; Research Institute for Diseases of Old Ages, Juntendo University, Faculty of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tracheobronchopathia osteochondroplastica (TO) is not only rare but also presents highly varied and unpredictable clinical manifestations. Consequently, the management and treatment strategies remain unclear. An accurate evaluation tool is important for the management of individual patients in the absence of standard guidelines. Although bronchoscopy is the gold standard for diagnosis, it cannot satisfactorily detect the treatment response and disease progression because subtle mucosal changes can go undetected. Therefore, improved techniques that can detect subtle mucosal changes associated with TO are desirable. Autofluorescence imaging bronchoscopy (AFI) is a recently introduced advanced endoscopic technology that can detect subtle mucosal changes with the aid of different colors. Here we report the first case, to the best of our knowledge, involving a 42-year-old man with TO in whom tracheal involvement was evaluated by AFI and detected as the appearance of a magenta color.

Indexed as

autofluorescence imaging bronchoscopy (AFI)squamous metaplasiaTracheobronchopathia osteochondroplastica (TO)

Identifiers

PMID27867586
PMCPMC5107479

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.